NCT07006389
Factors Affecting Response to Extracorporeal Shock Wave Therapy in Plantar Fasciitis: A Cross-sectional Clinical Study
StatusCompleted
PhaseNot specified
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 9 words Show 5 more changesShow less
- Primary endpoints: details revised at 1 of 4 entries
- Trial status changed: Enrolling by Invitation → Completed
- Enrollment target: estimated 128 to confirmed 124
- Study completion date changed from estimate of Jul 1, 2025 to Jul 15, 2025
- Secondary endpoints: details revised at 2 of 4 entries
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Calcaneal inclination angle
Timeframe: Day 1
Ankle dorsiflexion degree
Timeframe: Day 1
Plantar fascia thickness
Timeframe: Day 1
Tibial/plantar nerve conduction study with electroneuromyography
Timeframe: Day 1
Secondary (4)
Meary angle
Plantar calcaneal spurs
Heel Tenderness index
Foot Function Index
Arms and interventions
Non-responder group to ESWT
Patients who had less than 50% response in the Visual Analog Scale (VAS) after ESWT and patients who had \>50% VAS regression in the first month after ESWT and whose pain recurred afterwards
Responder group to ESWT
Patients who had \>50% VAS regression in the 6th month were included in the group that responded to ESWT treatment.
Sites
1 site in 1 country
- Şişli Hamidiye Etfal Training and Research HospitalIstanbul, Turkey (Türkiye)